In most research systems, technology transfer is organized one university at a time: each institution runs its own office, hires its own licensing staff, and builds its own relationships with industry. France took a different approach. Since 2012, the country has routed the bulk of public-research valorization through a network of regional intermediary companies called Sociétés d’Accélération du Transfert de Technologies (SATTs) — literally, “technology transfer acceleration companies” — each serving a cluster of universities, engineering schools, and public research organizations across a defined territory rather than a single institution. This guide covers what SATTs are, how the model is funded and governed, what they actually do in an invention’s lifecycle, and how the structure compares to the more decentralized US, UK, and Israeli approaches.
What a SATT is
A SATT is a private-law company — specifically a société par actions simplifiée (SAS, a simplified joint-stock company) — created to hold and exercise the technology-transfer function on behalf of multiple public research institutions in a given region, rather than each institution operating its own in-house office. The shareholders of a SATT are the public research and higher-education establishments in its territory (universities, grandes écoles, and public research organizations such as CNRS-affiliated units) together with the Caisse des Dépôts et Consignations (CDC), the French state’s public investment and deposit institution, which holds a stake on behalf of the state. No private, for-profit shareholders sit at the capital level — SATTs are wholly public-sector-owned companies operating under commercial company law.
Fourteen SATTs were originally created in three successive waves between 2012 and 2014, following a competitive call for proposals launched in 2010. Consolidation and rebranding since then (for example, SATT Grand Est operating today as Sayens) have left 13 SATTs currently active, organized under the umbrella Réseau SATT (the SATT Network), each covering a distinct region of France and typically serving a group of several to a dozen or more member institutions.
The founding rationale: pooling a function too specialized for any one university to run well
Before the SATT program, French universities’ capacity to manage invention disclosures, patent prosecution, proof-of-concept funding, and licensing negotiations varied enormously — a small regional university might see too few disclosures a year to justify a fully staffed, specialized transfer office, while the country’s research output as a whole was widely seen by policymakers as under-commercialized relative to its research volume. Rather than fund a technology transfer office at every institution, the state chose to fund one shared, professionally staffed company per region that would:
- centralize invention disclosure intake and initial patentability/commercial-potential screening across all its member institutions;
- provide proof-of-concept and maturation funding — money to advance a raw laboratory result to a state where it is credible to a licensee or investor — a function many individual university offices lack the budget to perform at scale;
- run patent prosecution and portfolio management centrally, giving smaller institutions access to specialized IP staff and outside counsel relationships they could not justify alone;
- market inventions to industry and negotiate licenses on behalf of the inventing institution, which retains ownership of the underlying IP; and
- support spinout formation where licensing to an existing company is not the right path.
The member institutions do not transfer ownership of resulting IP to the SATT — they remain the IP owner and licensor of record — but they delegate the operational work of getting an invention from disclosure to a signed deal, plus the maturation funding to get it there, to the shared regional entity.
How SATTs are funded
SATTs were created and initially capitalized under France’s Programme d’Investissements d’Avenir (PIA, the “Investments for the Future” program), a large state investment program launched in 2010 and administered principally through the Agence Nationale de la Recherche (ANR). Funding for the SATT program was drawn from the PIA’s National Valorization Fund and disbursed by the Caisse des Dépôts on the state’s behalf; commonly cited figures put the program’s initial endowment at roughly €856 million allocated across the network at launch, intended to cover both the SATTs’ own operating costs and the maturation/proof-of-concept funding they deploy into member institutions’ inventions. Individual SATTs also generate revenue from their own licensing and equity activity as their invention portfolios mature, reducing reliance on the initial state endowment over time.
The funding model has continued to evolve well past the initial PIA endowment. As the SATT Network’s own strategic reporting for 2025 describes, the state has been shifting the network’s recurring funding from the original PIA vehicle toward budget lines under the Research Programming Law (Loi de Programmation de la Recherche), alongside a broader push — under the France 2030 investment strategy — to fold SATT activity more closely into the national innovation ecosystem. Institutions and research-administration readers tracking SATT funding specifically should treat any single-year figure as provisional and check the network’s current reporting (satt.fr) rather than citing older PIA-era numbers as still current.
Governance
Each SATT has its own board, drawn from its shareholder institutions and the Caisse des Dépôts, and its own management team responsible for day-to-day operating decisions — investment in individual maturation projects, licensing strategy, and portfolio management for its territory. The network as a whole (Réseau SATT) coordinates shared practices, reporting, and advocacy across the 13 companies but does not centralize operational decision-making; each SATT functions as an independent company serving its own regional shareholder base, not as a branch office of a single national entity.
How this compares to other national models
The SATT structure is best understood by contrast with the models it deliberately departs from:
- United States and United Kingdom — decentralized, per-institution offices. In the US model that grew out of the Bayh-Dole Act, each university (or a small set of affiliated hospitals/institutes) typically runs its own technology licensing office or technology transfer office, staffed and funded independently, with no equivalent regional pooling layer. Well-resourced research universities build large, specialized in-house offices; smaller institutions with lower disclosure volume often struggle to justify equivalent staffing, and some contract out licensing functions to third-party firms rather than pooling with peer institutions the way SATT member universities do. The UK follows a broadly similar per-institution pattern, though with somewhat more use of shared regional or sector-specific commercialization vehicles than the US has historically had.
- Israel — per-university commercial subsidiaries. Israel’s model, covered in CASRAI’s guide to the Yissum/Yeda/Ramot model, also uses a dedicated corporate entity rather than an in-house university department — but each entity (Yissum at Hebrew University, Yeda at the Weizmann Institute, Ramot at Tel Aviv University, and equivalents elsewhere) is wholly owned by a single university, not shared across a region. It is the corporate-subsidiary structure of the French model without the multi-institution pooling.
- Germany — applied-research institutes, not a university transfer layer at all. Germany’s Fraunhofer-Gesellschaft model solves a related but distinct problem: rather than helping universities transfer inventions arising from investigator-led basic research, Fraunhofer runs its own network of applied-research institutes that perform contract research directly for industry, funded by a formula requiring roughly two-thirds of each institute’s budget to come from industry and competitive project revenue. It is not a technology-transfer intermediary for university IP at all, and is a useful contrast precisely because it addresses commercialization by relocating applied research itself rather than by centralizing the transfer function for university-generated inventions.
- South Korea and Japan — statute-driven university TLOs. Both countries built their systems around specific legislation requiring or incentivizing university-level technology licensing organizations — Japan’s original 1998 TLO Act and Korea’s Technology Transfer and Commercialization Promotion Act (in its current, renamed and amended form) — closer in structure to the US per-institution model than to France’s regional pooling, though both have state co-funding elements. See CASRAI’s guides on Japan’s TLO Act compared to Bayh-Dole and the South Korean university TLO system.
The common thread across the contrasts: France chose to solve uneven institutional capacity by pooling the transfer function itself across a region, with the state as a co-investing shareholder providing both operating funds and maturation capital. The US, Israeli, Japanese, and Korean models all keep the transfer function anchored at the individual institution (in-house office, wholly owned subsidiary, or statute-mandated TLO), varying mainly in ownership structure and state funding role rather than in whether pooling happens at all.
What this means for research administrators working with a SATT
An investigator or research-administration office at a French institution that is a SATT shareholder typically routes an invention disclosure to the regional SATT rather than to an in-house office, and the SATT — not the university’s own staff — handles patentability screening, prosecution decisions, and initial licensing conversations, while the university retains title to the resulting IP and receives its negotiated share of any licensing revenue per the shareholder agreement governing that SATT. For international collaborators or licensees evaluating a deal with a French university partner, understanding that the actual negotiating counterparty is often the regional SATT, not the university itself, is a practical point that affects who signs and who is bound by resulting license terms.
